
### [MONDO:0015703](http://purl.obolibrary.org/obo/MONDO_0015703)
**Label:** T-b+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta

**Subclasses:** [MONDO:0014278](http://purl.obolibrary.org/obo/MONDO_0014278) (immunodeficiency 18), [MONDO:0014280](http://purl.obolibrary.org/obo/MONDO_0014280) (immunodeficiency 19), [MONDO:0012426](http://purl.obolibrary.org/obo/MONDO_0012426) (immunodeficiency 25), 

**Corr. equiv. classes:** [OMIM:610163](http://purl.obolibrary.org/obo/OMIM_610163), [OMIM:615617](http://purl.obolibrary.org/obo/OMIM_615617), [OMIM:615615](http://purl.obolibrary.org/obo/OMIM_615615), 

**Class expressions from DL-Learner:**

- [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0012140](http://purl.obolibrary.org/obo/HP_0012140) (Abnormality of cells of the lymphoid lineage) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0011947](http://purl.obolibrary.org/obo/HP_0011947) (Respiratory tract infection) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0011893](http://purl.obolibrary.org/obo/HP_0011893) (Abnormal leukocyte count) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0005561](http://purl.obolibrary.org/obo/HP_0005561) (Abnormality of bone marrow cell morphology) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0004332](http://purl.obolibrary.org/obo/HP_0004332) (Abnormality of lymphocytes) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0003828](http://purl.obolibrary.org/obo/HP_0003828) (Variable expressivity) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0003828](http://purl.obolibrary.org/obo/HP_0003828) (Variable expressivity) and [HP:0005435](http://purl.obolibrary.org/obo/HP_0005435) (Impaired T cell function) 66.67%
- [HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability) and [HP:0030253](http://purl.obolibrary.org/obo/HP_0030253) (Defective T cell proliferation) 66.67%
- [HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability) and [HP:0005435](http://purl.obolibrary.org/obo/HP_0005435) (Impaired T cell function) 66.67%


